Literature DB >> 18230038

Central role of quorum sensing in regulating the production of pathogenicity factors in Pseudomonas aeruginosa.

Genevieve Girard1, Guido V Bloemberg.   

Abstract

Pseudomonas aeruginosa is an important opportunistic human pathogen, causing various infections that are often very persistent. P. aeruginosa infections are the major cause of death in cystic fibrosis patients. Infections are difficult to treat since P. aeruginosa is resistant to most antibiotics and its antibiotic susceptibility is decreased when it is present in biofilms. P. aeruginosa produces many exoproducts (including toxins and hydrolytic enzymes) that are involved in virulence. Recent research has elucidated many mechanisms and pathways that regulate the production of these virulence factors. The regulation is extremely complex and many components are influenced by environmental conditions. Quorum sensing is a key regulatory system, which itself is affected by many other regulators. Targeting the regulation of pathogenicity factors provides a novel strategy for combating P. aeruginosa infections. Degradation of acyl homoserine lactones, the signaling molecules of the quorum-sensing system, is a promising therapeutic treatment option.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18230038     DOI: 10.2217/17460913.3.1.97

Source DB:  PubMed          Journal:  Future Microbiol        ISSN: 1746-0913            Impact factor:   3.165


  29 in total

1.  Physiological framework for the regulation of quorum sensing-dependent public goods in Pseudomonas aeruginosa.

Authors:  Brett Mellbye; Martin Schuster
Journal:  J Bacteriol       Date:  2013-12-27       Impact factor: 3.490

Review 2.  Clinical significance of microbial infection and adaptation in cystic fibrosis.

Authors:  Alan R Hauser; Manu Jain; Maskit Bar-Meir; Susanna A McColley
Journal:  Clin Microbiol Rev       Date:  2011-01       Impact factor: 26.132

3.  GidA posttranscriptionally regulates rhl quorum sensing in Pseudomonas aeruginosa.

Authors:  Rashmi Gupta; Timothy R Gobble; Martin Schuster
Journal:  J Bacteriol       Date:  2009-07-10       Impact factor: 3.490

4.  Reducing Virulence and Biofilm of Pseudomonas aeruginosa by Potential Quorum Sensing Inhibitor Carotenoid: Zeaxanthin.

Authors:  Barış Gökalsın; Busecan Aksoydan; Burak Erman; Nüzhet Cenk Sesal
Journal:  Microb Ecol       Date:  2017-03-02       Impact factor: 4.552

5.  Evaluation of tumour necrosis factor-alpha and interleukin-1beta in an experimental pyelonephritis model induced with planktonic and biofilms cells of Pseudomonas aeruginosa.

Authors:  Rahul Mittal; Saroj Sharma; Sanjay Chhibber; Kusum Harjai
Journal:  Can J Infect Dis Med Microbiol       Date:  2009       Impact factor: 2.471

6.  Homeostatic interplay between bacterial cell-cell signaling and iron in virulence.

Authors:  Ronen Hazan; Jianxin He; Gaoping Xiao; Valérie Dekimpe; Yiorgos Apidianakis; Biliana Lesic; Christos Astrakas; Eric Déziel; François Lépine; Laurence G Rahme
Journal:  PLoS Pathog       Date:  2010-03-12       Impact factor: 6.823

7.  Lichen secondary metabolite evernic acid as potential quorum sensing inhibitor against Pseudomonas aeruginosa.

Authors:  Barış Gökalsın; Nüzhet Cenk Sesal
Journal:  World J Microbiol Biotechnol       Date:  2016-07-27       Impact factor: 3.312

8.  Global position analysis of the Pseudomonas aeruginosa quorum-sensing transcription factor LasR.

Authors:  Kerrigan B Gilbert; Tae Hoon Kim; Rashmi Gupta; E Peter Greenberg; Martin Schuster
Journal:  Mol Microbiol       Date:  2009-08-11       Impact factor: 3.501

9.  Instantaneous within-patient diversity of Pseudomonas aeruginosa quorum-sensing populations from cystic fibrosis lung infections.

Authors:  Cara N Wilder; Gopal Allada; Martin Schuster
Journal:  Infect Immun       Date:  2009-10-05       Impact factor: 3.441

Review 10.  Current treatment of pseudomonal infections in the elderly.

Authors:  Georgios Pappas; Kaiti Saplaoura; Matthew E Falagas
Journal:  Drugs Aging       Date:  2009       Impact factor: 3.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.